Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

FDA commissioner to depart

After six years on the job, FDA Commissioner Margaret Hamburg, MD, is stepping down, reports Clinical Innovation + Technology.

Thumbnail

Uptick in hiring at physician offices

January witnessed a significant increase in hiring at physician offices, reports Modern Healthcare.

Pfizer to acquire Hospira for $16B

In a deal that will transform the pharmaceutical industry, Pfizer announced that it will buy rival Hospira for $16 billion, reports Wall Street Journal.

Thumbnail

Under Armour buys MyFitnessPal, Endomondo for $560 million

Sports apparel maker Under Armour is continuing its push into the quantification of fitness and health with the acquisition of fitness apps MyFitnessPal for $475 million and Endomondo for $85 million.

Thumbnail

FDA Commissioner stepping down

Margaret Hamburg, MD, commissioner of the FDA, will step down from her position, according to multiple reports.

Thumbnail

ONC announces $8.4M in grants for workforce training, community health

The Office of the National Coordinator for Health IT is making available $8.1 million in new grant funding to improve community health and to build the health IT workforce.

Thumbnail

House GOP votes to repeal ACA

The GOP-controlled House passed legislation repealing the Affordable Care Act, with zero Democrats voting in favor of the bill, reports The New York Times.

ONC seeks 52% budget increase for 2016

The Obama administration is requesting a 52 percent budgetary increase for the Office of the National Coordinator for Health IT next year to support interoperability, “optimization” of health IT, consumer engagement in care and President Obama’s new Precision Medicine Initiative.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.